Morgan Stanley Call 55 AMBA 20.12.../ DE000ME9GF18 /
14/06/2024 18:31:13 | Var.- | Denaro11:51:32 | Lettera11:51:32 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.910EUR | - | 0.910 Quantità in denaro: 3,750 |
0.960 Quantità in lettera: 3,750 |
Ambarella Inc | 55.00 USD | 20/12/2024 | Call |
GlobeNewswire
12:04
Gilat to Acquire Stellar Blu, an IFC Market Leader with a First-to-Market ESA-Based Solution for Com...
GlobeNewswire
12:00
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-c...
GlobeNewswire
12:00
Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual ...
GlobeNewswire
12:00
Scott McGillivray Real Estate Trust II Joins addy Platform, Pioneering a New Era of Accessible Real ...
GlobeNewswire
12:00
Wawa’s Hoagiefest® is Back with $5 Shortis and $6 Classics and Four Additional Weeks of Savings! “Ke...
GlobeNewswire
12:00
Atomo Coffee Reveals Breakthrough Discovery to Instantly Slash Coffee-Related Deforestation, Urging ...
GlobeNewswire
12:00
Shoals Technologies Group to Launch Global Suite of Solutions at Intersolar Europe
GlobeNewswire
11:39
Correction: Amarna Therapeutics announces formation of Scientific Advisory Board to support advancem...
GlobeNewswire
11:23
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groun...
GlobeNewswire
10:20
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
Newsfile Corp
10:19
Shelf Gains Adaptation Among SMBs and Enterprises, Grows Double Digits in US and Canadian Market